130 related articles for article (PubMed ID: 8723192)
21. Progression of renal failure in analgesic-associated nephropathy.
Schwarz A; Kunzendorf U; Keller F; Offermann G
Nephron; 1989; 53(3):244-9. PubMed ID: 2797344
[TBL] [Abstract][Full Text] [Related]
22. Renal disease from habitual antipyretic analgesic consumption: an assessment of the epidemiologic evidence.
Buckalew VM; Schey HM
Medicine (Baltimore); 1986 Sep; 65(5):291-303. PubMed ID: 3489155
[TBL] [Abstract][Full Text] [Related]
23. Analgesic nephropathy. Clinical course after withdrawal of phenacetin.
Bell D; Kerr DN; Swinney J; Yeates WK
Br Med J; 1969 Aug; 3(5667):378-82. PubMed ID: 5797777
[TBL] [Abstract][Full Text] [Related]
24. Transitional cell carcinoma in renal transplant recipients: the influence of compound analgesics.
Swindle P; Falk M; Rigby R; Petrie J; Hawley C; Nicol D
Br J Urol; 1998 Feb; 81(2):229-33. PubMed ID: 9488064
[TBL] [Abstract][Full Text] [Related]
25. Significance of atypical urinary cytology in the evaluation of patients with end-stage renal disease for kidney transplantation - a retrospective study.
Law J; Ali O; Dobrin A; Brar H; Luke PP; Sener A
Transpl Int; 2019 Oct; 32(10):1085-1094. PubMed ID: 31100185
[TBL] [Abstract][Full Text] [Related]
26. Analgesic nephropathy: an important cause of chronic renal failure.
Cove-Smith JR; Knapp MS
Q J Med; 1978 Jan; 47(185):49-69. PubMed ID: 674550
[TBL] [Abstract][Full Text] [Related]
27. Diseases causing end-stage renal failure in New South Wales.
Stewart JH; McCarthy SW; Storey BG; Roberts BA; Gallery E; Mahony JF
Br Med J; 1975 Feb; 1(5955):440-3. PubMed ID: 1090338
[TBL] [Abstract][Full Text] [Related]
28. Unsuspected analgesic nephropathy in transitional cell carcinoma of the upper tract: a morphological study.
Lomax-Smith J; Seymour AE
Histopathology; 1980 May; 4(3):255-69. PubMed ID: 7390410
[TBL] [Abstract][Full Text] [Related]
29. The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review.
Boissier R; Hevia V; Bruins HM; Budde K; Figueiredo A; Lledó-García E; Olsburgh J; Regele H; Taylor CF; Zakri RH; Yuan CY; Breda A
Eur Urol; 2018 Jan; 73(1):94-108. PubMed ID: 28803033
[TBL] [Abstract][Full Text] [Related]
30. [Analgesics-induced chronic renal failure in patients on dialysis therapy in Hungary].
Pintér I; Mátyus J; Czégány Z; Harsányi J; Homoki M; Kassai M; Kiss E; Kiss I; Ladányi E; Lócsey L; Major L; Misz M; Nagy L; Polner K; Rédl J; Solt I; Tichy B; Török M; Varga G; Wagner G; Wórum I; Zsoldos B; Pótó L; Wittmann I; Nagy J
Orv Hetil; 2001 May; 142(19):1001-5. PubMed ID: 11419294
[TBL] [Abstract][Full Text] [Related]
31. [Analgesic nephropathy].
Kramer P
Med Klin; 1975 May; 70(20):889-95. PubMed ID: 1134426
[TBL] [Abstract][Full Text] [Related]
32. Primary urothelial carcinoma of the upper urinary tract in dialysis patients with 5-year follow-up.
Kang CH; Chen CH; Chiang PH
Jpn J Clin Oncol; 2010 Mar; 40(3):241-6. PubMed ID: 19933687
[TBL] [Abstract][Full Text] [Related]
33. Genitourinary Malignancies in Transplant or Dialysis Patients: The Frequency of Two Newly Described 2016 World Health Organization Histopathologic Types.
Billis A; Freitas LLL; Costa LBE; Barreto IS; Asato MA; Araujo KS; Losada DM; Herculiani AP; Tabosa GVBS; Zaidan BC; Oliveira GLP; Bastos LQA; Rocha RM
Transplant Proc; 2017 Oct; 49(8):1783-1785. PubMed ID: 28923625
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis.
Patel A; Soonawalla P; Shepherd SF; Dearnaley DP; Kellett MJ; Woodhouse CR
J Urol; 1996 Mar; 155(3):868-74. PubMed ID: 8583595
[TBL] [Abstract][Full Text] [Related]
35. De novo kidney graft tumors: results from a multicentric retrospective national study.
Tillou X; Doerfler A; Collon S; Kleinclauss F; Patard JJ; Badet L; Barrou B; Audet M; Bensadoun H; Berthoux E; Bigot P; Boutin JM; Bouzguenda Y; Chambade D; Codas R; Dantal J; Deturmeny J; Devonec M; Dugardin F; Ferrière JM; Erauso A; Feuillu B; Gigante M; Guy L; Karam G; Lebret T; Neuzillet Y; Legendre C; Perez T; Rerolle JP; Salomon L; Sallusto F; Sénéchal C; Terrier N; Thuret R; Verhoest G; Petit J;
Am J Transplant; 2012 Dec; 12(12):3308-15. PubMed ID: 22959020
[TBL] [Abstract][Full Text] [Related]
36. Analgesic use and risk of renal cell carcinoma: A case-control, cohort and meta-analytic assessment.
Karami S; Daughtery SE; Schwartz K; Davis FG; Ruterbusch JJ; Wacholder S; Graubard BI; Berndt SI; Hofmann JN; Purdue MP; Moore LE; Colt JS
Int J Cancer; 2016 Aug; 139(3):584-92. PubMed ID: 27009534
[TBL] [Abstract][Full Text] [Related]
37. Regular use of analgesics is a risk factor for renal cell carcinoma.
Gago-Dominguez M; Yuan JM; Castelao JE; Ross RK; Yu MC
Br J Cancer; 1999 Oct; 81(3):542-8. PubMed ID: 10507783
[TBL] [Abstract][Full Text] [Related]
38. Analgesic nephropathy.
Gault MH; Barrett BJ
Am J Kidney Dis; 1998 Sep; 32(3):351-60. PubMed ID: 9740150
[TBL] [Abstract][Full Text] [Related]
39. Declining incidence of analgesic nephropathy in Canada.
Wilson DR; Gault MH
Can Med Assoc J; 1982 Sep; 127(6):500-2. PubMed ID: 7116267
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis.
Denton MD; Magee CC; Ovuworie C; Mauiyyedi S; Pascual M; Colvin RB; Cosimi AB; Tolkoff-Rubin N
Kidney Int; 2002 Jun; 61(6):2201-9. PubMed ID: 12028461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
